Time Tested Since 1971
Cart 0

News

Summer 2019 IV Compatibility & Stability Updates

New and updated injectable drug compatibility and stability information added to the King Guide for Summer 2019.

Read more →


Y-Site Compatibility for Mobile Devices

Y-Site Compatibility for Mobile Devices

Mobile Device Y-Site Compatibility 2019 Y-site Compatibility of Critical Care Admixtures Quickly confirm the advisability of mixing intravenous drugs and determine if more in-depth information is needed from full text monographs provided in the complete King® Guide to Parenteral Admixtures®. Designed to report y-site compatibility of intravenous drugs commonly administered to hospital, ER, in-home and hospice care patients. 122 IV Drugs and 4 Infusion Fluids

Read more →


Winter 2018 Update

In this update we added a new drug monograph for PLAZOMICIN. We added new stability information for the existing drug monographs for AMIODARONE HYDROCHLORIDE, BORTEZOMIB, CISPLATIN, NOREPINEPHRINE BITARTRATE, PEMETREXED, RITUXIMAB, and VANCOMYCIN HYDROCHLORIDE. In addition, new compatibility information is reported for these existing monographs: CEFTRIAXONE SODIUM, LEVOFLOXACIN, and MILRINONE LACTATE, plus PLAZOMICIN with 92 other drugs.

Read more →


Fall 2018 Update

In this update we added new drug monographs for FOSFOMYCIN DISODIUM and ISONIAZID. We added new stability information for the existing drug monographs for ADENOSINE, MILRINONE LACTATE, and PROPOFOL. In addition, new compatibility information is reported for these existing monographs: CLONIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, HEPARIN SODIUM, KETAMINE HYDROCHLORIDE, LEVETIRACETAM, MICAFUNGIN SODIUM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, REMIFENTANIL HYDROCHLORIDE, SODIUM BICARBONATE, and SUFENTANIL CITRATE; and for FOSFOMYCIN DISODIUM with 95 different drugs.

Read more →


Summer 2018 IV Compatibility & Stability

In this supplement we added a new drug monograph for PLERIXAFOR with new stability and compatibility information. We added new stability information for the existing drug monographs for DECITABINE MESYLATE, EPINEPHRINE HYDROCHLORIDE, MEROPENEM AND VABORBACTAM, NOREPINEPHRINE BITARTRATE, OXALIPLATIN, ROLAPITANT HYDROCHLORIDE, and VALPROATE SODIUM. In addition, new compatibility information is reported for these existing monographs: BACLOFEN, DEXAMETHASONE SODIUM PHOSPHATE, MORPHINE SULFATE, PALONOSETRON HYDROCHLORIDE, ROLAPITANT HYDROCHLORIDE, and MEROPENEM AND VABORBACTAM with 88 different drugs.

Read more →